Overcoming PEG Antigenicity: Statistical PEG Isomers Reduce Antibody Binding.

Area of Science:

• Polymer Chemistry
• Immunology
• Nanomedicine

Background:

• Poly(ethylene glycol) (PEG) is crucial in bioconjugation and nanomedicine.
• PEG exposure can trigger anti-PEG antibodies (APAs), leading to immune reactions and rapid clearance.
• Developing PEG alternatives that evade immune recognition is essential.

Purpose of the Study:

• To investigate the interaction between randomized PEG (rPEG) and anti-PEG antibodies (APAs).
• To determine the efficacy of rPEG in preventing APA recognition and binding.
• To establish rPEG as a viable alternative to conventional PEG for biomedical uses.

Main Methods:

• Synthesis of rPEG via anionic ring-opening polymerization incorporating a glycidyl methyl ether comonomer.
• Characterization of rPEG-APA interactions using microscale thermophoresis and fluorescence correlation spectroscopy.
• Computational analysis using Monte Carlo simulations to assess PEG chain conformations.

Main Results:

• Increasing comonomer content in rPEG significantly reduced APA binding.
• rPEGs with 52 mol% comonomer effectively blocked APA interaction.
• Simulations showed reduced consecutive ethylene glycol sequences, crucial for APA recognition.

Conclusions:

• rPEG acts as a stealth polymer by hindering APA recognition.
• rPEG demonstrates potential as a superior alternative to PEG in biomedical applications.
• This work advances the development of biocompatible polymers with reduced immunogenicity.